Income Statement Hangzhou Tigermed Consulting Co., Ltd

Equities

300347

CNE100001KV8

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. 2026-03-13 5-day change 1st Jan Change
55.11 CNY -1.25% Intraday chart for Hangzhou Tigermed Consulting Co., Ltd -3.94% -2.80%
033fcd.JYwVrw-mhWQrRMkAwycNegAPTcwXF9iKI9zYj0QI6Sk.ScVUzWOU6jFhNqNVm3BLCVJ9dfohZrvDea-0zjxejUpD9XPJR8_KUUcujA
Published financial data: HANGZHOU TIGERMED CONSULTING CO., LTD
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW